SMA Newsroom

ResearchApr 29, 2022

New risdiplam data shows long-term improvement in babies with Type 1 SMA

The latest data from the FIREFISH study of risdiplam was presented at the 14th European Paediatric Neurology Society (EPNS) Congress.

ResearchMar 8, 2022

Biogen develops BIIB115, a potential new treatment for SMA

In response to our request, Biogen has shared a community update to announce that they are moving ahead with an early-stage investigation into a new treatment for SMA that could potentially treat further unmet needs.